Mylan Speclt Drug Patent Portfolio
Mylan Speclt owns 1 orange book drug protected by 6 US patents Given below is the list of Mylan Speclt's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6667344 | Bronchodilating compositions and methods | 22 Jun, 2021 | Expired |
| US6814953 | Bronchodilating compositions and methods | 22 Jun, 2021 | Expired |
| US7348362 | Bronchodilating β-agonist compositions and methods | 22 Jun, 2021 | Expired |
| US7462645 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 | Expired |
| US8623922 | Bronchodilating Beta-agonist compositions and methods | 22 Jun, 2021 | Expired |
| US9730890 | Bronchodilating beta-agonist compositions and methods | 22 Jun, 2021 | Expired |
Latest Legal Activities on Mylan Speclt's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mylan Speclt.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 20 Sep, 2021 | US9730890 |
|
Maintenance Fee Reminder Mailed
Critical
| 05 Apr, 2021 | US9730890 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Jun, 2020 | US7462645 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 18 Sep, 2019 | US7348362 |
|
Recordation of Patent Grant Mailed
Critical
| 15 Aug, 2017 | US9730890 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 15 Aug, 2017 | US9730890 |
|
Issue Notification Mailed
Critical
| 26 Jul, 2017 | US9730890 |
| Dispatch to FDC | 19 Jul, 2017 | US9730890 |
| Filing Receipt - Corrected | 19 Jul, 2017 | US9730890 |
| Mail-Record Petition Decision of Granted to Accept Delayed Payment of Issue Fee | 11 Jul, 2017 | US9730890 |
| Record Petition Decision of Granted to Accept Delayed Payment of Issue Fee | 11 Jul, 2017 | US9730890 |
| O.P. Petition Decision | 11 Jul, 2017 | US9730890 |
| Mail O.P. Petition Decision | 11 Jul, 2017 | US9730890 |
| Petition Entered | 17 Feb, 2017 | US9730890 |
| Supplemental Papers - Oath or Declaration | 17 Feb, 2017 | US9730890 |
Mylan Speclt's Family Patents
Mylan Speclt Drug List
Given below is the complete list of Mylan Speclt's drugs and the patents protecting them.
1. Perforomist
Perforomist is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6667344 | Bronchodilating compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US6814953 | Bronchodilating compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US7348362 | Bronchodilating β-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US7462645 | Bronchodilating beta-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US8623922 | Bronchodilating Beta-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
| US9730890 | Bronchodilating beta-agonist compositions and methods |
22 Jun, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Perforomist's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List